Table II.

Differentially expressed lncRNAs in patients with alcohol-related or non-alcohol-related hepatocellular carcinoma.

Top 20 upregulated lncRNAs				Top 20 downregulated lncRNAs
lncRNA	logFC	P-value	FDR	lncRNA	logFC	P-value	FDR
AC090921.1	5.26	1.35×10−50	7.79×10−47	ERVH48-1	−3.77	1.25×10−21	1.45×10−18
AL451074.6	3.15	2.17×10−35	6.29×10−32	AP000439.3	−4.73	3.49×10−17	2.89×10−14
AC007938.3	1.68	3.78×10−22	7.29×10−19	AC139749.1	−3.34	5.15×10−17	3.72×10−14
AC105446.1	2.58	6.40×10−22	9.26×10−19	LINC00473	−4.00	1.51×10−16	9.73×10−14
AC012640.1	1.94	2.45×10−18	2.36×10−15	LINC01480	−2.26	4.15×10−12	2.00×10−9
AC025627.1	1.26	6.31×10−13	3.65×10−10	AP000757.1	−1.61	2.31×10−10	7.86×10−8
AL445483.1	1.73	1.36×10−12	7.14×10−10	UCA1	−2.54	7.54×10−9	1.90×10−6
MYOSLID	1.59	1.35×10−11	6.03×10−9	AC064807.2	−1.85	9.35×10−9	2.16×10−6
EMX2OS	1.63	5.63×10−11	2.33×10−8	AL359853.1	−1.98	1.29×10−8	2.82×10−6
AC156455.1	1.18	1.15×10−10	4.17×10−8	PLCE1-AS1	−2.03	2.86×10−8	5.71×10−6
AP003354.2	1.27	6.76×10−10	2.17×10−7	AC002398.2	−2.03	9.19×10−8	1.77×10−5
AC007220.1	1.14	1.70×10−9	5.18×10−7	AC079305.1	−1.12	2.12×10−7	3.71×10−5
U62317.1	1.63	1.93×10−9	5.58×10−7	AC007099.1	−2.10	4.35×10−7	6.80×10−5
LINC02043	1.22	2.25×10−9	6.19×10−7	LINC01229	−1.32	7.07×10−7	1.02×10−4
AC068473.3	1.41	3.83×10−9	1.01×10−6	AC098869.2	−1.26	7.52×10−7	1.06×10−4
AC069431.1	1.42	8.70×10−9	2×10−6	LINC00624	−1.28	1.16×10−6	1.51×10−4
LINC01615	1.40	1.32×10−8	2.82×10−6	AC005674.1	−1.06	1.83×10−6	2.11×10−4
AC079779.2	1.50	2.35×10−8	4.86×10−6	AL161772.1	−1.24	2.26×10−6	2.52×10−4
AC062004.1	1.40	1.11×10−7	2.07×10−5	BX640514.2	−1.79	2.93×10−6	3.08×10−4
AL391056.1	1.574	1.21×10−7	2.18×10−5	AC023154.1	−1.44	3.44×10−6	3.46×10−4

lncRNAs, long noncoding RNAs; logFC, log2fold change; FDR, false discovery rate.